Search Results - "Francisco, Catherine"

Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial by Vestbo, Jørgen, Prof, Papi, Alberto, Prof, Corradi, Massimo, Prof, Blazhko, Viktor, MD, Montagna, Isabella, MSc, Francisco, Catherine, MSc, Cohuet, Géraldine, MSc, Vezzoli, Stefano, MSc, Scuri, Mario, MD, Singh, Dave, Prof

“…Summary Background Limited data are available for the efficacy of triple therapy with two long-acting bronchodilators and an inhaled corticosteroid in chronic…”
Get full text

Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2 -agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial by Singh, Dave, Prof, Papi, Alberto, Prof, Corradi, Massimo, Prof, Pavlišová, Ilona, MD, Montagna, Isabella, MSc, Francisco, Catherine, MSc, Cohuet, Géraldine, MSc, Vezzoli, Stefano, MSc, Scuri, Mario, MD, Vestbo, Jørgen, Prof

“…Summary Background Few data are available for the efficacy of “triple therapy” with two long-acting bronchodilators and an inhaled corticosteroid in chronic…”
Get full text

Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study by Singh, Dave, Emirova, Aida, Francisco, Catherine, Santoro, Debora, Govoni, Mirco, Nandeuil, Marie Anna

“…Background This study evaluated the efficacy, safety and tolerability of the novel inhaled phosphodiesterase-4 inhibitor CHF6001 added-on to formoterol in…”
Get full text

Beclometasone–formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial by Papi, Alberto, Prof, Corradi, Massimo, MD, Pigeon-Francisco, Catherine, MSc, Baronio, Roberta, MSc, Siergiejko, Zenon, Prof, Petruzzelli, Stefano, MD, Fabbri, Leonardo M, Prof, Rabe, Klaus F, Prof

“…Summary Background According to international treatment guidelines, inhaled rapid-acting β2 agonists should be used for the control of symptoms in patients…”
Get full text

Extrafine beclomethasone/formoterol combination via a dry powder inhaler (NEXThaler® ) or pMDI and beclomethasone monotherapy for maintenance of asthma control in adult patients: A randomised, double-blind trial by Kanniess, Frank, Scuri, Mario, Vezzoli, Stefano, Francisco, Catherine, Petruzzelli, Stefano

“…Abstract Background The fixed combination of extrafine beclomethasone dipropionate and formoterol fumarate (BDP/FF) pMDI (Foster® ) is approved for treatment…”
Get full text

Single inhaler triple therapy versus inhaled corticosteroid plus long-acting [beta]2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial by Singh, Dave, Papi, Alberto, Corradi, Massimo, Pavlisová, Ilona, Montagna, Isabella, Francisco, Catherine, Cohuet, Géraldine, Vezzoli, Stefano, Scuri, Mario, Vestbo, Jørgen

“…Few data are available for the efficacy of "triple therapy" with two long-acting bronchodilators and an inhaled corticosteroid in chronic obstructive pulmonary…”
Get full text

Single inhaler triple therapy versus inhaled corticosteroid plus long-acting beta 2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial by Singh, Dave, Papi, Alberto, Corradi, Massimo, Pavlisova, Ilona, Montagna, Isabella, Francisco, Catherine, Cohuet, Geraldine, Vezzoli, Stefano, Scuri, Mario, Vestbo, Joergen

“…Background Few data are available for the efficacy of "triple therapy" with two long-acting bronchodilators and an inhaled corticosteroid in chronic…”
Get full text

Prostate Cancer: Two Steps Forward: New tests may cut down on unnecessary biopsies by Catherine Arnst in San Francisco

“…Prostate cancer has certainly gained a higher profile in recent years. The American Cancer Society estimates that 318,000 new cases will be diagnosed in the US…”
Get full text